The global medical foam market size is estimated at USD 27.7 billion in 2020 and is projected to reach USD 37.2 billion by 2025, at a CAGR of 6.1% from 2020 to 2025. The bedding & cushioning segment was the largest application of medical foam owing to a rise in the geriatric population and an increase in health-related concerns in the aged population leading to high demand for comfort and orthopedic support. The increase in the health expenditure of several countries has led to growth in the market for medical foam.
Major companies such as The Dow Chemical Company (US), SEKISUI CHEMICAL CO., LTD. (Japan), Huntsman Corporation (US), Trelleborg AB (Sweden), BASF SE (Germany), Recticel NV (Belgium), INOAC Corporation (Japan), UFP Technologies, Inc. (US), FXI Holdings, Inc. (US), Armacell International S.A. (Germany), Rogers Corporation (US), Freudenberg Group (Germany), Mölnlycke Health Care AB (Sweden), VPC Group Inc. (Canada), FoamPartner Group (Switzerland), The Woodbridge Group (Canada), General Plastics Manufacturing Company (US), and others are key players in the global medical foam market. These players have been focusing on developmental strategies, such as expansions, mergers & acquisitions, partnerships, and new product launches & developments, which have helped them expand their businesses in untapped and potential markets. They have also been adopting various organic and inorganic growth strategies, such as mergers & acquisitions, and expansions, to enhance their current positions in the medical foam market.
To know about the assumptions considered for the study download the pdf brochure
The Dow Chemical Company is one of the leaders in the chemical industry and a global leader in the medical foam market. The company has a global presence with several manufacturing sites and sales offices. The Dow Chemical Company offers several products of polyurethane foam for applications such as bedding & cushioning and packaging. The foams offered by the company are highly resilient and viscoelastic foams that provide high comfort. The company has a limited presence in emerging markets of the Asia Pacific region. Hence, it could adopt some growth strategies such as acquisitions or mergers with existing players in the region. This could help the company increase its market presence in this untapped region.
SEKISUI CHEMICAL CO., LTD. is a Japanese firm offering various solutions such as polyethylene, urethanes, and polyurethanes for polymer consumers. The company provides medical foam under the brands Softlon and Volara, which are developed by using irradiated cross-linking technology and are nearly 100% closed-cell foam. The company operates and distributes products in North America, Europe, Central/South America, China, Japan, and Asia & Oceania. SEKISUI CHEMICAL CO., LTD. is expanding its business through inorganic growth strategies such as expansion to meet the growing demand for medical-grade foam.
- In November 2017, SEKISUI CHEMICAL CO., LTD. established a polyolefin foam plant in Thailand through the THAI SEKISUI FOAM CO., LTD. division of the company. The company expanded its foam production line to meet the increasing demand for foam from the construction, medical, automotive, and other sectors. With this increase in production, the company was able to produce 5-million-meters square of polyolefin foam per year.
Huntsman Corporation is one of the leading players in the North America region that provides flexible foams for medical applications. Additionally, the company is one of the major players in the isocyanates market. The company has over 75 manufacturing, R&D, and operation facilities in around 30 countries across the globe. The company is involved in the manufacturing of flexible and rigid foam for bedding & cushioning and medical device & component applications. The company concentrates on organic growth strategies such as expansion to increase its product offerings and market presence. For example, the company has plans to expand its polyurethane foam manufacturing facilities to serve customers in North America and other regions.
Request for Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=176803616
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Media Contact
Company Name: MarketsandMarkets
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/medical-foam-market-176803616.html